https://bostonharborangels.com/2024/09/17/revbio-receives-a-2-4-million-nih-grant-to-conduct-a-first-in-human-clinical-trial-for-its-regenerative-bone-adhesive-for-cranial-flap-fixation-and-enrolls-first-five-patients/
RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its...
RevBio, Inc., announced that it has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of...